The leukemia team at University Hospitals Seidman Cancer Center in Cleveland, Ohio focuses on improving and extending the lives of leukemia patients with excellent clinical care and the development of new and improved treatments. From diagnosis and treatment – including stem cell transplant if necessary – through survivorship, our team supports patients at every step during their care journey. Our nationally recognized researchers and clinicians are at the forefront of leukemia research and discovery, making important discoveries in advancing the diagnosis and treatment of the disease.
Referrals and Consultations
To refer a patient or schedule a consultation with a leukemia specialist, contact our malignant hematology nurse navigator for UH Seidman Cancer Center at 216-286-6537.
Patients can also be referred to our main UH Seidman Cancer Center scheduling number at 216-844-3951.
Our dedicated lymphoma team includes physician specialists, nurse practitioners and nurse navigators who specialize in lymphoma-specific diagnosis and treatment. The same team takes care of each patient through every step of treatment, including stem cell transplant when needed. We take a multidisciplinary approach to care, reviewing each case as part of the hematologic malignancy tumor board. Dedicated to advancing the diagnosis and treatment of the disease, our nationally recognized researchers and clinicians are at the front line of lymphoma research and discovery.
View Lymphoma Clinical Trials
Referrals and Consultations
To refer a patient or schedule a consultation with a lymphoma specialist, contact our main UH Seidman Cancer Center scheduling number at 216-844-3951.
Our team delivers state-of-the-art disease management with a multidisciplinary approach, integrating the latest medical technologies, minimally invasive therapies and research. From diagnosis through treatment and ongoing myeloma management, including stem cell transplant if needed, the same clinical team directs and follows each patient’s care.
Clinical Trials for Multiple Myeloma Patients
At UH Seidman Cancer Center, our physician-scientists are engaged in advancing medicine through research and discovery. With access to myeloma-specific clinical trials, our patients can benefit from the latest therapies, including:
- Monoclonal antibodies for targeted anti-myeloma therapy
- Minimal residual disease (MRD) detection
- Other immunotherapies
Our experts leverage the most recent advances in multiple myeloma care to make treatment safer, more tolerable and more effective for patients.
Referrals and Consultations
To refer a patient or schedule a consultation with a multiple myeloma specialist, contact our malignant hematology nurse navigator for UH Seidman Cancer Center at 216-286-6537.
Patients can also be referred to our main UH Seidman Cancer Center scheduling number at 216-844-3951.
